カテゴリー： Market Monitor Global, 世界, 医療/バイオ

脊椎固定用生物製剤の世界市場見通し2023年-2029年

◆英語タイトル：Spinal Fusion Biologics Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8015 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：78 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Spinal Fusion Biologics Market 調査レポートは次の情報を含め、グローバルにおけるの脊椎固定用生物製剤市場規模と予測を収録しています。・世界の脊椎固定用生物製剤市場：売上、2018年-2023年、2024年-2029年
・世界の脊椎固定用生物製剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の脊椎固定用生物製剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「骨移植片」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

脊椎固定用生物製剤のグローバル主要企業は、Medtronic、 J &J (DePuy Synthes)、 SeaSpine、 Xtant Medical、 Zimmer Biomet、 Stryker、 Straumann、 Wright Medical Group、 Hans Biomed、 Arthrexなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、脊椎固定用生物製剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の脊椎固定用生物製剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の脊椎固定用生物製剤市場：タイプ別市場シェア、2022年
・骨移植片、骨移植片代替品、多血小板血漿（PRP）、その他

世界の脊椎固定用生物製剤市場：用途別、2018年-2023年、2024年-2029年
世界の脊椎固定用生物製剤市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の脊椎固定用生物製剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の脊椎固定用生物製剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における脊椎固定用生物製剤のグローバル売上、2018年-2023年
・主要企業における脊椎固定用生物製剤のグローバル売上シェア、2022年
・主要企業における脊椎固定用生物製剤のグローバル販売量、2018年-2023年
・主要企業における脊椎固定用生物製剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Medtronic、 J &J (DePuy Synthes)、 SeaSpine、 Xtant Medical、 Zimmer Biomet、 Stryker、 Straumann、 Wright Medical Group、 Hans Biomed、 Arthrex

*************************************************************

・調査・分析レポートの概要
脊椎固定用生物製剤市場の定義
市場セグメント
世界の脊椎固定用生物製剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脊椎固定用生物製剤市場規模
世界の脊椎固定用生物製剤市場規模：2022年 VS 2029年
世界の脊椎固定用生物製剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脊椎固定用生物製剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の脊椎固定用生物製剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：骨移植片、骨移植片代替品、多血小板血漿（PRP）、その他
脊椎固定用生物製剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
脊椎固定用生物製剤の用途別グローバル売上・予測

・地域別市場分析
地域別脊椎固定用生物製剤市場規模 2022年と2029年
地域別脊椎固定用生物製剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Medtronic、 J &J (DePuy Synthes)、 SeaSpine、 Xtant Medical、 Zimmer Biomet、 Stryker、 Straumann、 Wright Medical Group、 Hans Biomed、 Arthrex
...

Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.
This report aims to provide a comprehensive presentation of the global market for Spinal Fusion Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Fusion Biologics. This report contains market size and forecasts of Spinal Fusion Biologics in global, including the following market information:
Global Spinal Fusion Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Spinal Fusion Biologics Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Spinal Fusion Biologics companies in 2022 (%)
The global Spinal Fusion Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Bone Graft Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Spinal Fusion Biologics include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Spinal Fusion Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Fusion Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, by Type, 2022 (%)
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Global Spinal Fusion Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Spinal Fusion Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Spinal Fusion Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Fusion Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Spinal Fusion Biologics revenues share in global market, 2022 (%)
Key companies Spinal Fusion Biologics sales in global market, 2018-2023 (Estimated), (Units)
Key companies Spinal Fusion Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Outline of Major Chapters:
Chapter 1: Introduces the definition of Spinal Fusion Biologics, market overview.
Chapter 2: Global Spinal Fusion Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Spinal Fusion Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Spinal Fusion Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Spinal Fusion Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Spinal Fusion Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Fusion Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Fusion Biologics Overall Market Size
2.1 Global Spinal Fusion Biologics Market Size: 2022 VS 2029
2.2 Global Spinal Fusion Biologics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Spinal Fusion Biologics Sales: 2018-2029
3 Company Landscape
3.1 Top Spinal Fusion Biologics Players in Global Market
3.2 Top Global Spinal Fusion Biologics Companies Ranked by Revenue
3.3 Global Spinal Fusion Biologics Revenue by Companies
3.4 Global Spinal Fusion Biologics Sales by Companies
3.5 Global Spinal Fusion Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Spinal Fusion Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Spinal Fusion Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Spinal Fusion Biologics Players in Global Market
3.8.1 List of Global Tier 1 Spinal Fusion Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Spinal Fusion Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Spinal Fusion Biologics Market Size Markets, 2022 & 2029
4.1.2 Bone Graft
4.1.3 Bone Graft Substitute
4.1.4 Platelet Rich Plasma (PRP)
4.1.5 Other
4.2 By Type – Global Spinal Fusion Biologics Revenue & Forecasts
4.2.1 By Type – Global Spinal Fusion Biologics Revenue, 2018-2023
4.2.2 By Type – Global Spinal Fusion Biologics Revenue, 2024-2029
4.2.3 By Type – Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
4.3 By Type – Global Spinal Fusion Biologics Sales & Forecasts
4.3.1 By Type – Global Spinal Fusion Biologics Sales, 2018-2023
4.3.2 By Type – Global Spinal Fusion Biologics Sales, 2024-2029
4.3.3 By Type – Global Spinal Fusion Biologics Sales Market Share, 2018-2029
4.4 By Type – Global Spinal Fusion Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Spinal Fusion Biologics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Spinal Fusion Biologics Revenue & Forecasts
5.2.1 By Application – Global Spinal Fusion Biologics Revenue, 2018-2023
5.2.2 By Application – Global Spinal Fusion Biologics Revenue, 2024-2029
5.2.3 By Application – Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
5.3 By Application – Global Spinal Fusion Biologics Sales & Forecasts
5.3.1 By Application – Global Spinal Fusion Biologics Sales, 2018-2023
5.3.2 By Application – Global Spinal Fusion Biologics Sales, 2024-2029
5.3.3 By Application – Global Spinal Fusion Biologics Sales Market Share, 2018-2029
5.4 By Application – Global Spinal Fusion Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Spinal Fusion Biologics Market Size, 2022 & 2029
6.2 By Region – Global Spinal Fusion Biologics Revenue & Forecasts
6.2.1 By Region – Global Spinal Fusion Biologics Revenue, 2018-2023
6.2.2 By Region – Global Spinal Fusion Biologics Revenue, 2024-2029
6.2.3 By Region – Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
6.3 By Region – Global Spinal Fusion Biologics Sales & Forecasts
6.3.1 By Region – Global Spinal Fusion Biologics Sales, 2018-2023
6.3.2 By Region – Global Spinal Fusion Biologics Sales, 2024-2029
6.3.3 By Region – Global Spinal Fusion Biologics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Spinal Fusion Biologics Revenue, 2018-2029
6.4.2 By Country – North America Spinal Fusion Biologics Sales, 2018-2029
6.4.3 US Spinal Fusion Biologics Market Size, 2018-2029
6.4.4 Canada Spinal Fusion Biologics Market Size, 2018-2029
6.4.5 Mexico Spinal Fusion Biologics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Spinal Fusion Biologics Revenue, 2018-2029
6.5.2 By Country – Europe Spinal Fusion Biologics Sales, 2018-2029
6.5.3 Germany Spinal Fusion Biologics Market Size, 2018-2029
6.5.4 France Spinal Fusion Biologics Market Size, 2018-2029
6.5.5 U.K. Spinal Fusion Biologics Market Size, 2018-2029
6.5.6 Italy Spinal Fusion Biologics Market Size, 2018-2029
6.5.7 Russia Spinal Fusion Biologics Market Size, 2018-2029
6.5.8 Nordic Countries Spinal Fusion Biologics Market Size, 2018-2029
6.5.9 Benelux Spinal Fusion Biologics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Spinal Fusion Biologics Revenue, 2018-2029
6.6.2 By Region – Asia Spinal Fusion Biologics Sales, 2018-2029
6.6.3 China Spinal Fusion Biologics Market Size, 2018-2029
6.6.4 Japan Spinal Fusion Biologics Market Size, 2018-2029
6.6.5 South Korea Spinal Fusion Biologics Market Size, 2018-2029
6.6.6 Southeast Asia Spinal Fusion Biologics Market Size, 2018-2029
6.6.7 India Spinal Fusion Biologics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Spinal Fusion Biologics Revenue, 2018-2029
6.7.2 By Country – South America Spinal Fusion Biologics Sales, 2018-2029
6.7.3 Brazil Spinal Fusion Biologics Market Size, 2018-2029
6.7.4 Argentina Spinal Fusion Biologics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Spinal Fusion Biologics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Spinal Fusion Biologics Sales, 2018-2029
6.8.3 Turkey Spinal Fusion Biologics Market Size, 2018-2029
6.8.4 Israel Spinal Fusion Biologics Market Size, 2018-2029
6.8.5 Saudi Arabia Spinal Fusion Biologics Market Size, 2018-2029
6.8.6 UAE Spinal Fusion Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Spinal Fusion Biologics Major Product Offerings
7.1.4 Medtronic Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 J &J (DePuy Synthes)
7.2.1 J &J (DePuy Synthes) Company Summary
7.2.2 J &J (DePuy Synthes) Business Overview
7.2.3 J &J (DePuy Synthes) Spinal Fusion Biologics Major Product Offerings
7.2.4 J &J (DePuy Synthes) Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.2.5 J &J (DePuy Synthes) Key News & Latest Developments
7.3 SeaSpine
7.3.1 SeaSpine Company Summary
7.3.2 SeaSpine Business Overview
7.3.3 SeaSpine Spinal Fusion Biologics Major Product Offerings
7.3.4 SeaSpine Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.3.5 SeaSpine Key News & Latest Developments
7.4 Xtant Medical
7.4.1 Xtant Medical Company Summary
7.4.2 Xtant Medical Business Overview
7.4.3 Xtant Medical Spinal Fusion Biologics Major Product Offerings
7.4.4 Xtant Medical Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.4.5 Xtant Medical Key News & Latest Developments
7.5 Zimmer Biomet
7.5.1 Zimmer Biomet Company Summary
7.5.2 Zimmer Biomet Business Overview
7.5.3 Zimmer Biomet Spinal Fusion Biologics Major Product Offerings
7.5.4 Zimmer Biomet Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Zimmer Biomet Key News & Latest Developments
7.6 Stryker
7.6.1 Stryker Company Summary
7.6.2 Stryker Business Overview
7.6.3 Stryker Spinal Fusion Biologics Major Product Offerings
7.6.4 Stryker Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Stryker Key News & Latest Developments
7.7 Straumann
7.7.1 Straumann Company Summary
7.7.2 Straumann Business Overview
7.7.3 Straumann Spinal Fusion Biologics Major Product Offerings
7.7.4 Straumann Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Straumann Key News & Latest Developments
7.8 Wright Medical Group
7.8.1 Wright Medical Group Company Summary
7.8.2 Wright Medical Group Business Overview
7.8.3 Wright Medical Group Spinal Fusion Biologics Major Product Offerings
7.8.4 Wright Medical Group Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Wright Medical Group Key News & Latest Developments
7.9 Hans Biomed
7.9.1 Hans Biomed Company Summary
7.9.2 Hans Biomed Business Overview
7.9.3 Hans Biomed Spinal Fusion Biologics Major Product Offerings
7.9.4 Hans Biomed Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Hans Biomed Key News & Latest Developments
7.10 Arthrex
7.10.1 Arthrex Company Summary
7.10.2 Arthrex Business Overview
7.10.3 Arthrex Spinal Fusion Biologics Major Product Offerings
7.10.4 Arthrex Spinal Fusion Biologics Sales and Revenue in Global (2018-2023)
7.10.5 Arthrex Key News & Latest Developments
8 Global Spinal Fusion Biologics Production Capacity, Analysis
8.1 Global Spinal Fusion Biologics Production Capacity, 2018-2029
8.2 Spinal Fusion Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Spinal Fusion Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Spinal Fusion Biologics Supply Chain Analysis
10.1 Spinal Fusion Biologics Industry Value Chain
10.2 Spinal Fusion Biologics Upstream Market
10.3 Spinal Fusion Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Spinal Fusion Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Spinal Fusion Biologics in Global Market
Table 2. Top Spinal Fusion Biologics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Spinal Fusion Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Spinal Fusion Biologics Revenue Share by Companies, 2018-2023
Table 5. Global Spinal Fusion Biologics Sales by Companies, (Units), 2018-2023
Table 6. Global Spinal Fusion Biologics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Spinal Fusion Biologics Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Spinal Fusion Biologics Product Type
Table 9. List of Global Tier 1 Spinal Fusion Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Spinal Fusion Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Spinal Fusion Biologics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Spinal Fusion Biologics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Spinal Fusion Biologics Sales (Units), 2018-2023
Table 15. By Type - Global Spinal Fusion Biologics Sales (Units), 2024-2029
Table 16. By Application – Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Spinal Fusion Biologics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Spinal Fusion Biologics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Spinal Fusion Biologics Sales (Units), 2018-2023
Table 20. By Application - Global Spinal Fusion Biologics Sales (Units), 2024-2029
Table 21. By Region – Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Spinal Fusion Biologics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Spinal Fusion Biologics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Spinal Fusion Biologics Sales (Units), 2018-2023
Table 25. By Region - Global Spinal Fusion Biologics Sales (Units), 2024-2029
Table 26. By Country - North America Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Spinal Fusion Biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Spinal Fusion Biologics Sales, (Units), 2018-2023
Table 29. By Country - North America Spinal Fusion Biologics Sales, (Units), 2024-2029
Table 30. By Country - Europe Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Spinal Fusion Biologics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Spinal Fusion Biologics Sales, (Units), 2018-2023
Table 33. By Country - Europe Spinal Fusion Biologics Sales, (Units), 2024-2029
Table 34. By Region - Asia Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Spinal Fusion Biologics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Spinal Fusion Biologics Sales, (Units), 2018-2023
Table 37. By Region - Asia Spinal Fusion Biologics Sales, (Units), 2024-2029
Table 38. By Country - South America Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Spinal Fusion Biologics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Spinal Fusion Biologics Sales, (Units), 2018-2023
Table 41. By Country - South America Spinal Fusion Biologics Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Spinal Fusion Biologics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Spinal Fusion Biologics Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Spinal Fusion Biologics Sales, (Units), 2024-2029
Table 46. Medtronic Company Summary
Table 47. Medtronic Spinal Fusion Biologics Product Offerings
Table 48. Medtronic Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Medtronic Key News & Latest Developments
Table 50. J &J (DePuy Synthes) Company Summary
Table 51. J &J (DePuy Synthes) Spinal Fusion Biologics Product Offerings
Table 52. J &J (DePuy Synthes) Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. J &J (DePuy Synthes) Key News & Latest Developments
Table 54. SeaSpine Company Summary
Table 55. SeaSpine Spinal Fusion Biologics Product Offerings
Table 56. SeaSpine Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. SeaSpine Key News & Latest Developments
Table 58. Xtant Medical Company Summary
Table 59. Xtant Medical Spinal Fusion Biologics Product Offerings
Table 60. Xtant Medical Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Xtant Medical Key News & Latest Developments
Table 62. Zimmer Biomet Company Summary
Table 63. Zimmer Biomet Spinal Fusion Biologics Product Offerings
Table 64. Zimmer Biomet Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Zimmer Biomet Key News & Latest Developments
Table 66. Stryker Company Summary
Table 67. Stryker Spinal Fusion Biologics Product Offerings
Table 68. Stryker Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Stryker Key News & Latest Developments
Table 70. Straumann Company Summary
Table 71. Straumann Spinal Fusion Biologics Product Offerings
Table 72. Straumann Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Straumann Key News & Latest Developments
Table 74. Wright Medical Group Company Summary
Table 75. Wright Medical Group Spinal Fusion Biologics Product Offerings
Table 76. Wright Medical Group Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Wright Medical Group Key News & Latest Developments
Table 78. Hans Biomed Company Summary
Table 79. Hans Biomed Spinal Fusion Biologics Product Offerings
Table 80. Hans Biomed Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Hans Biomed Key News & Latest Developments
Table 82. Arthrex Company Summary
Table 83. Arthrex Spinal Fusion Biologics Product Offerings
Table 84. Arthrex Spinal Fusion Biologics Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Arthrex Key News & Latest Developments
Table 86. Spinal Fusion Biologics Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Spinal Fusion Biologics Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Spinal Fusion Biologics Production by Region, 2018-2023 (Units)
Table 89. Global Spinal Fusion Biologics Production by Region, 2024-2029 (Units)
Table 90. Spinal Fusion Biologics Market Opportunities & Trends in Global Market
Table 91. Spinal Fusion Biologics Market Drivers in Global Market
Table 92. Spinal Fusion Biologics Market Restraints in Global Market
Table 93. Spinal Fusion Biologics Raw Materials
Table 94. Spinal Fusion Biologics Raw Materials Suppliers in Global Market
Table 95. Typical Spinal Fusion Biologics Downstream
Table 96. Spinal Fusion Biologics Downstream Clients in Global Market
Table 97. Spinal Fusion Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Spinal Fusion Biologics Segment by Type in 2022
Figure 2. Spinal Fusion Biologics Segment by Application in 2022
Figure 3. Global Spinal Fusion Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Spinal Fusion Biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Spinal Fusion Biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. Spinal Fusion Biologics Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Spinal Fusion Biologics Revenue in 2022
Figure 9. By Type - Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 12. By Type - Global Spinal Fusion Biologics Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 16. By Application - Global Spinal Fusion Biologics Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Spinal Fusion Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Spinal Fusion Biologics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 21. By Country - North America Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 23. US Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 28. Germany Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 29. France Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 37. China Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 41. India Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 44. Brazil Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Spinal Fusion Biologics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Spinal Fusion Biologics Sales Market Share, 2018-2029
Figure 48. Turkey Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Spinal Fusion Biologics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Spinal Fusion Biologics Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Spinal Fusion Biologics by Region, 2022 VS 2029
Figure 54. Spinal Fusion Biologics Industry Value Chain
Figure 55. Marketing Channels

※参考情報

脊椎固定用生物製剤は、脊椎手術の際に使用される医療材料の一種であり、主に骨折や変性疾患、脊椎の不安定性に対する治療に利用されます。この製剤は、脊椎の安定化を目的としており、骨融合を促進するために設計されています。近年、脊椎外科における生物製剤の役割は注目を浴びており、治療効果を高めるための選択肢が増加しています。

脊椎固定用生物製剤は、基本的に骨再生や骨融合を促進する物質を含んでいます。これらの製剤は、天然由来の材料や合成された材料で構成されており、それぞれの特徴を生かして脊椎手術に応用されます。生物製剤は、骨代謝に必要な成分や成長因子を提供し、骨の癒合を加速する役割を果たします。このような製剤は、患者の治癒を早め、手術後の回復を向上させることが期待されています。

脊椎固定用生物製剤には、いくつかの種類があります。生物学的に活性な成分を含む製剤として、まず骨移植材料が挙げられます。これは、他の部位から採取された骨を利用し、再生医療において重要な役割を果たします。また、骨形成促進因子や骨吸収抑制因子などを含む製剤もあります。これにより、骨の生理的なプロセスを促進し、骨の結合を強化することが可能となります。

具体的な製剤の一例として、成長因子を用いた製剤があります。これらは、特に骨髄由来の間葉系幹細胞や骨形成因子を利用しており、骨の再生能力を高めることが証明されています。これらの因子は、骨細胞の分化を促進し、骨融合を効果的に進行させることで、治療結果を改善します。

さらに、人工的に合成された生物材料もあります。これらは、生体適合性が高く、機械的特性が優れており、骨の代用品として使用されます。また、合成材料は、製造過程で特定の特性を持たせることが可能であり、治療に合わせた個別化が実現できます。これにより、患者の状態や病態に応じた最適な選択が可能となります。

脊椎固定用生物製剤の用途は多岐にわたり、主に脊椎手術における骨融合に利用されます。特に、脊椎椎間板ヘルニアや脊椎不安定性、変性疾患に伴う手術において、患者の症状を軽減し、機能回復を図るために用いられます。また、外傷性の骨折に対しても、早期の骨癒合を促進するために活用されます。

関連技術としては、骨再生医療や再生因子の応用が挙げられます。近年の研究では、組織工学的手法も取り入れられており、より効果的な骨再生が期待されています。細胞ベースの治療法や、ナノテクノロジーを用いた生物製剤の開発も進められており、より安全で効果的な治療法が模索されています。

また、脊椎固定用生物製剤は、様々な手術法との組み合わせによっても効果を発揮します。特に、最小侵襲手術法や内視鏡手術との併用によって、患者の負担を軽減しつつ、高い治療効果を得ることが可能です。これにより、手術後の回復期間が短縮され、患者の生活の質が向上することが期待されています。

まとめとして、脊椎固定用生物製剤は、脊椎手術において重要な役割を果たす医療材料であり、骨融合を促進するためのさまざまな種類と技術が開発されています。生物学的に活性な成分や人工的に合成された材料を用いて、治療効果を高めることが目指されています。今後も、さらなる研究が進められ、効果的で安全な治療法が提供されることが期待されています。脊椎外科の領域における技術革新は、患者に新しい希望をもたらし、より良い治療結果を実現するために不可欠です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脊椎固定用生物製剤の世界市場見通し2023年-2029年(Spinal Fusion Biologics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

脊椎固定用生物製剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp